PlatformHealthcare
Corten and Ampersand acquire Beacon Intelligence
The drug development intelligence platform serves over 300 customers including 24 of the 30 largest pharmaceutical companies and was carved out from Hanson Wade Group.
- Target
- Beacon Intelligence
- Sponsors
- Corten Capital, Ampersand Capital Partners
- Source
- GlobeNewswire